19 results
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
28 Apr 23
Current report (foreign)
4:05pm
that environmental considerations are embedded in our supplier selection process. We remain accountable for understanding the environmental impact of our supply
6-K
EX-10.1
zy7trdkpqnd5yoe 6km2
19 Jul 21
Calliditas secures $75 million term loan facility
7:20am
20-F
uw97y1bssi2u ci88r
27 Apr 21
Annual report (foreign)
5:16pm
F-1
EX-10.14
91j e1tajlaryvro
26 Jan 21
Registration statement (foreign)
4:33pm
F-1
6sljso bs325ym4gphyu
26 Jan 21
Registration statement (foreign)
4:33pm
DRS
fnml9
29 Dec 20
Draft registration statement
12:00am
424B4
3ocbtrvt4 fg98y1cmng
8 Jun 20
Prospectus supplement with pricing info
9:18am
F-1/A
btzrb
1 Jun 20
Registration statement (foreign) (amended)
7:01am
F-1
7ngvo9
14 May 20
Registration statement (foreign)
8:56am
F-1
EX-10.12
ngcnwfz260ja
14 May 20
Registration statement (foreign)
8:56am
DRS/A
qw6ex14v9qbhq
2 Mar 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
oocep
2 Mar 20
Draft registration statement (amended)
12:00am
DRS
l4hs 18qxx6w9q
13 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next